Highlights AxoGen, Inc.

Equities

AXGN

US05463X1063

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
6.63 ^USD	+1.69%		+2.00%	-2.93%

Mar. 08	Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing	MT
Mar. 08	AxoGen, Inc. Announces Executive Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Down After Mixed Earnings -- Health Care Roundup	Mar. 05	DJ
AxoGen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
AxoGen, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Mar. 05	CI
North American Morning Briefing : S&P 500 Futures -2-	Mar. 05	DJ
Axogen, Inc. Announces Positive Topline Results from Its REPOSE Clinical Study	Jan. 18	CI
Axogen Expects Higher Q4 Revenue; CEO Plans to Retire	Jan. 04	MT
AxoGen, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023	Jan. 04	CI
AxoGen, Inc. Revises Revenue Guidance for the Full Year of 2023	Jan. 04	CI
AxoGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (AXGN) AXOGEN Posts Q3 Revenue $41.3M, vs. Street Est of $40.3M	Nov. 07	MT
Earnings Flash (AXGN) AXOGEN Posts Q3 EPS $0.01, vs. Street Est of $-0.06	Nov. 07	MT
AXOGEN INC - CONTINUES TO EXPECT GROSS MARGIN FOR FULL YEAR 2023…	Nov. 07	RE
Axogen, Inc. Provides Revenue Guidance for the Full-Year 2023	Nov. 07	CI
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector	23-09-05	CI
Earnings Flash (AXGN) AXOGEN Reports Q2 Revenue $38.2M, vs. Street Est of $39.1M	23-08-07	MT
Axogen, Inc. Provides Revenue Guidance for the Year 2023	23-08-07	CI
AxoGen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Axogen, Inc. Reiterates Revenue Guidance for the Year 2023	23-05-09	CI
Earnings Flash (AXGN) AXOGEN Posts Q1 Revenue $36.7M, vs. Street Est of $35.5M	23-05-09	MT
AxoGen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AxoGen, Inc.

Equities

AXGN

US05463X1063

Highlights

Filters